1,995 results on '"Hanauer, Stephen B."'
Search Results
2. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
3. Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent—A case-control study
4. Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial
5. Surgery for Crohn’s Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts
6. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
7. Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer
8. Association between inflammatory bowel disease and prostate cancer: A large‐scale, prospective, population‐based study
9. COVID-19 and Inflammatory Bowel Disease
10. Patient Perspectives on Medical Trauma Related to Inflammatory Bowel Disease
11. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease
12. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
13. Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results
14. Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT‐UC Consortium.
15. Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis.
16. The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
17. AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
18. Surgery for Crohn’s Disease Is Associated with a Dysbiotic Microbiome and Metabolome: Results from Two Prospective Cohorts
19. Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer
20. Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNA
21. Management of Chronic Pouchitis
22. Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate)
23. Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis
24. Inflammatory Bowel Disease and the Risk of Prostate Cancer
25. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease – the Evolving Landscape
26. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Practice Update: Commentary
27. The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease
28. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease
29. Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease
30. Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis
31. Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing
32. The Evolving Role of Thiopurines in Inflammatory Bowel Disease
33. Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent—A case-control study
34. Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies
35. S874 Impact of Atovaquone and Proguanil on Steroid Use, Hospitalization, and Advanced Therapeutic Use in Patients With IBD: A Propensity Matched Cohort Study
36. S875 Atovaquone and Proguanil vs Hepatitis A Vaccine, Hydroxychloroquine, and Mesalamine in Patients With IBD: A Propensity Score Matched Cohort Comparison of Strategically Selected Comparators
37. S1130 Network Meta-Analysis to Evaluate the Comparative Efficacy of Biologics for Maintenance Treatment of Adult Patients With Crohn’s Disease
38. S892 Outpatient Biologic Therapy is Associated With Worse Outcomes During and After Admissions for Acute Severe Ulcerative Colitis
39. S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study
40. Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study
41. The importance of predicting patient responses to monoclonal antibodies for Crohn’s disease
42. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes
43. Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
44. ADVANCES IN IBD. Reviewing Recommendations for Vaccines and Health Care Maintenance in Patients With Inflammatory Bowel Disease... Francis A. Farraye.
45. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
46. Identification of Novel Susceptibility Loci for Inflammatory Bowel Disease on Chromosomes 1p, 3q, and 4q: Evidence for Epistasis between 1p and IBD1
47. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
48. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis ,
49. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
50. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.